Treatment of adult rhabdoid renal cell carcinoma with sorafenib

Auteurs-es

  • Anil Kapoor Division of Urology, Department of Surgery; and Section of Genito-Urinary Oncology, Juravinski Cancer Centre, McMaster University, Hamilton, Ont.
  • Robert Tutino Division of Urology, Department of Surgery, McMaster University, Hamilton, Ont.
  • Androniki Kanaroglou Division of Urology, Department of Surgery, McMaster University, Hamilton, Ont.
  • Sebastien J. Hotte Section of Genito-Urinary Oncology, Juravinski Cancer Centre, Hamilton, Ont.

DOI :

https://doi.org/10.5489/cuaj.983

Résumé

Renal cell carcinoma (RCC) with rhabdoid features is an uncommon and highly aggressive malignancy. We report a case of adult clear-cell RCC with extensive rhabdoid features treated with the tyrosine kinase inhibitor sorafenib. A review of the literature summarizes important aspects of this malignancy. We discuss clinical and histological findings as well as the patient’s response to sorafenib therapy.

Téléchargements

Les données relatives au téléchargement ne sont pas encore disponibles.

Téléchargements

Publié-e

2008-12-01

Comment citer

Kapoor, A., Tutino, R., Kanaroglou, A., & Hotte, S. J. (2008). Treatment of adult rhabdoid renal cell carcinoma with sorafenib. Canadian Urological Association Journal, 2(6), 631. https://doi.org/10.5489/cuaj.983

Numéro

Rubrique

Case Report